A phase Ib, open-label, single arm study to assess the safety, pharmacokinetics, and impact on humoral sensitization of SANGUINATE infusion in patients with end-stage renal disease. (Q47593297)
Jump to navigation
Jump to search
scientific article published on 15 November 2017
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A phase Ib, open-label, single arm study to assess the safety, pharmacokinetics, and impact on humoral sensitization of SANGUINATE infusion in patients with end-stage renal disease. |
scientific article published on 15 November 2017 |
Statements
1 reference
A phase Ib, open-label, single arm study to assess the safety, pharmacokinetics, and impact on humoral sensitization of SANGUINATE infusion in patients with end-stage renal disease. (English)
1 reference
Paul Brailey
Tonya Dorst
Mouhamad H Abdallah
Amit Govil
Daniel Byczkowski
Hemant Misra
Abraham Abuchowski
15 November 2017
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference